Brief: Senores Pharmaceuticals Says Investment Of $468,640 In SPI Through Rights Issue
20/03/2025 10:50
March 20 (Reuters) - Senores Pharmaceuticals Ltd SENO.NS: INVESTMENT OF $468,640 IN SPI THROUGH RIGHTS ISSUE Source text: ID:nNSE9RpTpL Further company coverage: SENO.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees